sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
1-Sep-2015 12:12
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 951-975 out of 1090.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>

Public Release: 13-Dec-2013
Acta Tropica
Snail fever expected to decline in Africa due to climate change
The dangerous parasite Schistosoma mansoni that causes snail fever in humans could become significantly less common in the future a new international study led by researchers from the University of Copenhagen predicts. The results are surprising because they contradict the general assumption that climate change leads to greater geographical spread of diseases. The explanation is that the parasite's host snails stand to lose suitable habitat due to climate change.

Contact: Post doc Anna-Sofie Stensgaard
University of Copenhagen

Public Release: 12-Dec-2013
UCSF receives $15 million for malaria elimination campaign
UC San Francisco's Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.
Bill & Melinda Gates Foundation

Contact: Laura Kurtzman
University of California - San Francisco

Public Release: 11-Dec-2013
Proceedings of the Royal Society B
Hormones in the crosshairs
When it comes to hunting, anthropologists and evolutionary scientists have long wondered -- and debated -- what, exactly, is the motivating factor behind hunting. Do men take down game for the purpose of feeding their families, or is there an element of showmanship and the hope of gaining access to healthier, more fertile mates?

Contact: Andrea Estrada
University of California - Santa Barbara

Public Release: 11-Dec-2013
Cell Host & Microbe
Scientists discover chemical modification in human malaria parasite DNA
University of California, Riverside researchers who are trying to understand the biology of Plasmodium, the human malaria parasite, have discovered a potential weakness--low levels of DNA methylation in Plasmodium's genome that may be critical to the survival of the parasite. Until now, the existence of DNA methylation -- a biochemical process involving the modification of DNA -- in the Plasmodium parasite was disputable.
National Institutes of Health, National Science Foundation

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 11-Dec-2013
Cell Host & Microbe
Choreographed stages of Salmonella infection revealed by Liverpool scientists
Scientists have used a new method to map the response of every salmonella gene to conditions in the human body, providing new insight into how the bacteria triggers infection.
Science Foundation Ireland, University of Liverpool

Contact: Jamie Brown
University of Liverpool

Public Release: 10-Dec-2013
American Journal of Clinical Nutrition
Malnourished children still have hope beyond first 1,000 days
New research from Brigham Young University is finding that global health workers should not give up on impoverished children after the first 1,000 days. In a longitudinal study of 8,000 children from four poverty-laden countries, BYU health science assistant professor Ben Crookston and colleagues found that the developmental damage of malnutrition during the first 1,000 days is not irreversible.
National Institues of Health, Gates Foundation, Grand Challenges Canada

Contact: Todd Hollingshead
Brigham Young University

Public Release: 10-Dec-2013
New way to finance health in world's less developed nations
Countries and major donors are changing the way they finance maternal and child, malaria, tuberculosis and HIV/AIDS health programs in low-income countries to increase their impact. The approach, called Results-Based Financing for Health, or RBF, pays providers or recipients of health services after pre-agreed results have been achieved and independently verified.

Contact: Nils Hoffman
Hoffman & Hoffman Worldwide

Public Release: 10-Dec-2013
Antibiotic-resistant typhoid likely to spread despite drug control program
Restricting the use of antibiotics is unlikely to stop the spread of drug resistance in typhoid fever, according to a study funded by the Wellcome Trust and published in the journal eLife.
Wellcome Trust

Contact: Jen Middleton
Wellcome Trust

Public Release: 5-Dec-2013
PLOS Neglected Tropical Diseases
Stripped mobile phone camera turned into a mini-microscope for low-cost diagnostics
Simple imaging devices modified to inexpensive mini-microscopes are the new weapon in fight against tropical infectious diseases, show the researchers at the Institute for Molecular Medicine Finland, FIMM, University of Helsinki and Karolinska Institutet.

Contact: Dr. Johan Lundin
University of Helsinki

Public Release: 5-Dec-2013
NIH-funded scientists describe how mosquitoes are attracted to humans
Scientists at the University of California, Riverside have shown that certain mosquito nerve cells, known as cpA neurons, cause mosquitoes to be attracted to humans by detecting exhaled carbon dioxide and odors emitted from human skin. Their findings, published Dec. 5 in the journal Cell, may have implications for the control of mosquitoes and the diseases they transmit. The study was supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Nalini Padmanabhan
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 5-Dec-2013
Rise in R&D funding could set stage for malaria eradication by providing new tools
A new analysis of funding trends in the global battle against malaria reveals that, over the last two decades, there has been a five-fold increase in annual funding for malaria research and development--from US$131 million in 1993 to $610 million in 2011. Much of that increase took place after 2004, when support stood at $320 million.

Contact: Preeti Singh
PATH Malaria Vaccine Initiative

Public Release: 5-Dec-2013
How mosquitoes are drawn to human skin and breath
Scientists at the University of California, Riverside have found that the very receptors in the mosquito's maxillary palp that detect carbon dioxide are ones that detect skin odors as well, thus explaining why mosquitoes are attracted to skin odor -- smelly socks, worn clothes, bedding -- even in the absence of carbon dioxide. Using a chemical computational method they developed, the researchers identified affordable, safe and pleasant-smelling compounds that could find use in mosquito control.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, University of California Global Health Institute, Bill and Melinda Gates Foundation

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 5-Dec-2013
New insights into how human skin attracts mosquitoes could lead to better repellants and traps
Every time a mosquito is lured to the scent of your skin, you're at risk of contracting malaria, dengue fever, West Nile virus, or another deadly disease. A new study reveals an important class of neurons responsible for a mosquito's attraction to human skin odor, as well as odors that stimulate and inhibit the activity of these neurons. The findings could lead to a new generation of repellants and traps for effective mosquito control worldwide.

Contact: Mary Beth O'Leary
Cell Press

Public Release: 4-Dec-2013
Research & development for diseases of the poor: A 10-year analysis of impact of the DNDi model
Today, at a scientific meeting at Institut Pasteur, France, entitled 'Best Science for the Most Neglected: Where Do We Stand Ten Years On?', co-organized with Institut Pasteur and MSF and in collaboration with PLOS, the Drugs for Neglected Diseases initiative marks its 10-year anniversary by issuing a report exploring the lessons learned from a decade of research and development of new treatments for neglected diseases via a cost-effective, innovative, not-for-profit drug development model.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 2-Dec-2013
Antimicrobial Agents and Chemotherapy
Scientists present groundbreaking HIV prevention research
Researchers at the Oak Crest Institute of Science are making history by proving that it's possible to develop a drug delivery system that has the potential to protect women from sexually transmitted HIV and herpes simplex virus, while at the same time preventing unintended pregnancy. The report in the journal of Antimicrobial Agents and Chemotherapy describes in vivo results from a novel, multipurpose pod-intravaginal ring delivering three antiretroviral drugs in combination with two hormonal contraceptives.

Contact: Dr. Marc M. Baum
Oak Crest Institute of Science

Public Release: 2-Dec-2013
Proceedings of the National Academy of Sciences
Culling vampire bats to stem rabies in Latin America can backfire
Culling vampire bat colonies to stem the transmission of rabies in Latin America does little to slow the spread of the virus and could even have the reverse effect, according to University of Michigan researchers and their colleagues.
National Science Foundation, University of Georgia, Centers for Disease Control and Prevention

Contact: Jim Erickson
University of Michigan

Public Release: 2-Dec-2013
New report illustrates persistent global burden of anemia among high-risk populations
Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly among young children and women, according to a new report on trends in anemia between 1990 and 2010.

Contact: Amanda Szabo
American Society of Hematology

Public Release: 2-Dec-2013
USAID awards CONRAD and Eastern Virginia Medical School funding for development of new HIV prevention
Richard V. Homan, MD, President and Provost of Eastern Virginia Medical School (EVMS) and Dean of the School of Medicine, along with Alfred Z. Abuhamad, Chair and Professor of EVMS Obstetrics and Gynecology, announced today that CONRAD, a leading reproductive health-research organization at the school, will receive up to $80 million over the course of five years from the United States President's Emergency Plan for AIDS Relief through the US Agency for International Development.
US President's Emergency Plan for AIDS Relief, US Agency for International Development

Contact: Annette Larkin

Public Release: 28-Nov-2013
Proceedings of the National Academy of Sciences
Researchers pinpoint superbug resistance protein
Researchers identified a resistance protein that allows a "superbug" to survive a disinfectant used in hospitals.
International Research Staff Exchange Scheme

Contact: c.j.bunting@leeds.ac.uk
University of Leeds

Public Release: 27-Nov-2013
Study finds vulnerability in malaria parasite
An international team of scientists, including researchers at Columbia University Medical Center, has identified a key metabolic enzyme that common malaria parasites require for survival at each stage of infection in humans. The findings raise the possibility of a new approach to combating malaria, one of the world's deadliest diseases. The study was published today in the online edition of the journal Nature.
Welcome Trust, Medicines for Malaria Venture

Contact: Karin Eskenazi
Columbia University Medical Center

Public Release: 27-Nov-2013
Annals of Oncology
Global study reveals pandemic of untreated cancer pain due to over-regulation of pain medicines
A ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world's population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain.

Contact: Vanessa Pavinato
European Society for Medical Oncology

Public Release: 27-Nov-2013
New England Journal of Medicine
The good news about the global epidemic of dementia
As many Americans share holiday meals with family members whose memories are impaired, here's some good news about dementia, in the New England Journal, from Eric B. Larson, MD, MPH, of Group Health Research Institute; Kristine Yaffe, MD, of the University of California, San Francisco; and Kenneth M. Langa, MD, PhD, of the University of Michigan: The age-adjusted rate of cases seems to be declining worldwide with more education, prosperity, and prevention of vascular risk.

Contact: Rebecca Hughes
Group Health Research Institute

Public Release: 26-Nov-2013
Antimicrobial Agents and Chemotherapy
Treatment target identified for a public health risk parasite
In the developing world, Cryptosporidium parvum has long been the scourge of freshwater. Its rapid ability to spread, combined with an incredible resilience to water decontamination techniques, such as chlorination, led the National Institutes of Health in the United Sates to add C. parvum to its list of public bioterrorism agents. Currently, there are no reliable treatments for cryptosporidiosis, but that may be about to change with the identification of a target molecule by MUHC investigators.
Sandler Foundation, Montreal General Hospital Foundation, Research Institute, McGill University Health Centre

Contact: Julie Robert
514-934-1934 x71381
McGill University Health Centre

Public Release: 26-Nov-2013
BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom
The department of radiology at Boston University School of Medicine and Boston Medical Center is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.
Grand Challenges Explorations

Contact: Jenny Eriksen Leary
Boston University Medical Center

Public Release: 21-Nov-2013
Study of fluke parasites identifies drug resistance mutations; raises hope for new therapies
An international group of scientists lead by Tim Anderson Ph.D., at the Texas Biomedical Research Institute and Philip LoVerde Ph.D., at the University of Texas Health Science Center at San Antonio has identified the mutations that result in drug resistance in a parasite infecting 187 million people in South America, Africa and Asia. The new finding allows detailed understanding of the drugs' mechanism of action and raises prospects of improved therapies.
National Institutes of Health, World Health Organization, Wellcome Trust

Contact: Tim Anderson
Texas Biomedical Research Institute

Showing releases 951-975 out of 1090.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>